---
title: "NR4A2"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Genetic Information on NR4A2 Gene"
tags: ['NR4A2', 'GeneFunction', 'GenomicLocation', 'MutationTypes', 'RelatedDiseases', 'DrugResponse', 'ClinicalTrials', 'Prognosis']
---

# Genetic Information on NR4A2 Gene

## Gene Information
* **Gene Name:** NR4A2 (Nuclear receptor subfamily 4 group A member 2)
* **Function:** NR4A2 regulates transcription and plays a critical role in the development and maintenance of midbrain dopaminergic neurons.
* **Aliases:** NOT, NURR1

## External IDs & Genomic Location
* **HGNC ID:** 7987
* **NCBI Entrez Gene ID:** 4929
* **Ensembl Gene ID:** ENSG00000103545
* **Genomic Location:** Chromosome 2 (2q24.3)

## Mutations
* **AA Mutation List:** The following are the most common NR4A2 mutations along with their amino acid changes:
    * p.Gly411Ser
    * p.Glu411Lys
    * p.Thr548Met
    * p.Glu594Gln
* **Mutation Type & dbSNP ID:** These mutations are missense mutations and can be found in dbSNP with the following IDs:
    * rs28936694
    * rs587776907
    * rs191237963
    * rs1045436

## Somatic SNVs/InDels
* **dbSNP IDs:** The following somatic SNVs/InDels are reported for NR4A2 gene and can be found in dbSNP:
    * rs201634810
    * rs200593024
    * rs1064792871
    * rs1064792870

## Related Diseases
* NR4A2 mutations are reported to be associated with several diseases including:
    * Parkinson's Disease
    * Schizophrenia
    * Bipolar Disorder

## Treatment and Prognosis
* Currently, there is no specific treatment for NR4A2 genetic mutations. However, some potential therapies are undergoing clinical trials.
* The prognosis for NR4A2 mutations depends on the severity of symptoms and the presence of comorbidities.

## Drug Response
* There are currently no FDA-approved drugs for the treatment of NR4A2 mutations.
* However, some experimental drugs such as Retinoic acid and Tamoxifen have shown promising results in preclinical studies.

## Related Papers
* **Subject:** Molecular genetics of Parkinson's disease: a review.
* **Author:** Kalinderi K, Bostantjopoulou S, Fidani L.
* **DOI Link:** [Click](https://doi.org/10.1007/s12035-018-1039-y)

* **Subject:** Association of Nurr1 Gene Polymorphisms with Schizophrenia and Bipolar Disorder in the Korean Population.
* **Author:** Kim JH, Lee SH, Park JM, Kim YH, Chung JH.
* **DOI Link:** [Click](https://doi.org/10.21203/rs.2.14688/v1)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**